Herui Yao
0000-0001-5520-6469
Publication & Citation Trends
Publications
0 total
De-escalation of axillary surgery after neoadjuvant therapy in breast cancer: long-term outcomes of sentinel lymph node biopsy alone versus complete axillary lymph node dissection
Cited by 1
Semantic Scholar
MRI-Based Multimodal AI Model Enables Prediction of Recurrence Risk and Adjuvant Therapy in Breast Cancer. OA
Cited by 17
Semantic Scholar
Single-cell RNA sequencing identifies CD8Teff cell activation as a predictive biomarker in triple-negative breast cancer immunotherapy
Cited by 0
Semantic Scholar
Abstract P4-03-30: GPR56/ADGRG1 promotes the progression of triple-negative breast cancer by enhancing PKM2/LDH-mediated glycolysis via the PI3K/AKT/mTOR/HIF-1α pathway
Cited by 1
Semantic Scholar
A foundation model for predicting outcomes of neoadjuvant chemotherapy in breast cancer.
Cited by 0
Semantic Scholar
Deep learning-based multi-modal data integration enhancing breast cancer disease-free survival prediction OA
Cited by 26
Semantic Scholar
Unraveling the role of M1 macrophage and CXCL9 in predicting immune checkpoint inhibitor efficacy through multicohort analysis and single‐cell RNA sequencing OA
Cited by 21
Semantic Scholar
Research Topics
HER2/EGFR in Cancer Research
(66)
MicroRNA in disease regulation
(54)
Cancer-related molecular mechanisms research
(48)
Advanced Breast Cancer Therapies
(46)
Cancer Treatment and Pharmacology
(41)
Affiliations
Qingdao University
Macau University of Science and Technology
Beijing Normal University - Hong Kong Baptist University United International College
Hong Kong Baptist University
Sun Yat-sen University